| A replacement-first approach to toxicity testing is necessary to successfully reauthorize TSCA. | |
| | |
MedLine Citation:
|
PMID: 22130480 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
The Toxic Substances Control Act is the principal US law governing industrial chemicals. Over the past three and one half decades, it has become clear that a considerable toxicological information gap exists about chemicals in commerce. The current provisions of the US TSCA law have failed to fill, and perhaps even exacerbated, that gap. For at least the past 5 years, bills have been introduced before the US Congress to reauthorize TSCA.Filling the toxicological information gap has been one of the driving forces for this call for substantial change. This article describes efforts to modernize TSCA, with an emphasis on the new provisions that would be put into place if the legislation became law. The article shows that only by implementing a "replacement-first" strategy - a strategy that is not currently incorporated into TSCA reauthorization efforts - can TSCA modernization efforts potentially fill the toxic data voids. |
| | |
Authors:
|
Paul A Locke; D Bruce Myers |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: ALTEX Volume: 28 ISSN: 1868-596X ISO Abbreviation: ALTEX Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-12-01 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100953980 Medline TA: ALTEX Country: Germany |
Other Details:
|
Languages: eng Pagination: 266-72 Citation Subset: IM |
Affiliation:
|
Johns Hopkins Bloomberg School of Public Health, Department of Environmental Health Sciences, Center for Alternatives to Animal testing, Baltimore, MD, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Plasma adiponectin elevation in elderly individuals with subsyndromal depression.
Next Document: How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?